Industry News
Pharmaceutical Industry News
Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahoma
Johnson & Johnson scores reversal of landmark $465M opioid ruling in Oklahoma esagonowsky Tue, 11/09/2021 - 14:27
Regeneron and Novo Nordisk hold tight at the top spots on October list of biggest TV ad spenders
Regeneron and Novo Nordisk hold tight at the top spots on October list of biggest TV ad spenders sharon.coey Tue, 11/09/2021 - 12:25
Biogen’s Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame?
Biogen's Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame? aliu Tue, 11/09/2021 - 11:35
As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster use
As BioNTech raises expected COVID-19 vaccine sales to $19.6B, CEO stumps for wider booster use kdunleavy Tue, 11/09/2021 - 11:21
Judge overturns $2.4M whistleblower retaliation verdict against AstraZeneca
Judge overturns $2.4M whistleblower retaliation verdict against AstraZeneca esagonowsky Tue, 11/09/2021 - 10:47
Bayer’s Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chief
Bayer’s Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chief aliu Tue, 11/09/2021 - 10:20
Improving immunotherapy delivery by bringing order to tumor blood vessels
Improving immunotherapy delivery by bringing order to tumor blood vessels ntaylor Tue, 11/09/2021 - 09:47
With filing in sight, Opiant’s nasal opioid overdose drug boards FDA fast track
With filing in sight, Opiant's nasal opioid overdose drug boards FDA fast track ntaylor Tue, 11/09/2021 - 09:43
Genentech backs song created by and for people with spinal muscular atrophy to elevate people with disabilities
Genentech backs song created by and for people with spinal muscular atrophy to elevate people with disabilities nmissakian Tue, 11/09/2021 - 09:34
Biohaven taps Pfizer for global Nurtec push in deal worth up to $1.24B
Biohaven taps Pfizer for global Nurtec push in deal worth up to $1.24B esagonowsky Tue, 11/09/2021 - 09:24
With Merck’s oral COVID-19 med molnupiravir set for authorization, U.S. spends another $1B for 1.4 million courses
With Merck's oral COVID-19 med molnupiravir set for authorization, U.S. spends another $1B for 1.4 million courses kdunleavy Tue, 11/09/2021 - 08:56
With Merck’s oral COVID-19 med molnupiravir set for authorization, U.S. spends another $1B for 1.4M courses
With Merck's oral COVID-19 med molnupiravir set for authorization, U.S. spends another $1B for 1.4M courses kdunleavy Tue, 11/09/2021 - 08:56
Almac on global hiring binge for 1,800 new positions as the CDMO expands
Almac on global hiring binge for 1,800 new positions as the CDMO expands jkeenan Tue, 11/09/2021 - 07:44
GSK’s ViiV turns to Black women’s experiences in latest season of award-winning podcast
GSK's ViiV turns to Black women's experiences in latest season of award-winning podcast sharon.coey Tue, 11/09/2021 - 02:39
Samsung Pharm hit with 3-month production suspension from Korean regulators
Samsung Pharm hit with 3-month production suspension from Korean regulators jkeenan Mon, 11/08/2021 - 12:07
Lilly and Boehringer’s Jardiance shows benefits for those with ‘intimately linked’ heart failure and kidney disease
Lilly and Boehringer's Jardiance shows benefits for those with 'intimately linked' heart failure and kidney disease kdunleavy Mon, 11/08/2021 - 11:18
Bristol Myers Squibb’s Opdivo posts another win in early lung cancer, but debate over treatment approach likely remains
Bristol Myers Squibb's Opdivo posts another win in early lung cancer, but debate over treatment approach likely remains aliu Mon, 11/08/2021 - 10:08
Regeneron’s antibody cocktail can protect against COVID-19 for up to 8 months, giving hope to the immunocompromised
Regeneron's antibody cocktail can protect against COVID-19 for up to 8 months, giving hope to the immunocompromised kdunleavy Mon, 11/08/2021 - 09:31
Regeneron’s antibody cocktail protects against COVID-19 for up to 8 months, giving hope to the immunocompromised
Regeneron's antibody cocktail protects against COVID-19 for up to 8 months, giving hope to the immunocompromised kdunleavy Mon, 11/08/2021 - 09:31
Japan’s Meiji Seika to build $20.1M manufacturing plant in India
Japan's Meiji Seika to build $20.1M manufacturing plant in India jkeenan Mon, 11/08/2021 - 08:58